Astilbin Inhibits the Proliferation and Induces Apoptosis of Gastric Cancer Cells (AGS) by Targeting the Key Inflammatory Markers
Guoshan Zhang1, Xiaoyuan Zhuang1, Shen Lin2, Yatian Wang1★★ Corresponding author
- 1Department of Gastroenterology, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China
- 2Department of Internal Medicine, Jinan Authority Hospital, Jinan, Shandong Province, China
CORRESPONDENCE
Yatian Wang
Department of Gastroenterology, Central Hospital Affiliated to Shandong First Medical University, No. 105, Jiefang Road, Lixia District, Jinan, Shandong Province 250013, China.
Received: 04-03-2024; Accepted: 06-06-2024.
Volume 20, Issue 4 · pp. 1276–1285 · PUBLISHED 2024 · DOI: 10.1177/09731296241264612
View on Pharmacogn. Mag. original site ↗
ABSTRACT
Background: The predisposition toward gastrointestinal disease is increasing as a result of dietary changes and overindulgence in food preparation. Ninety percent of stomach cancers are adenocarcinomas, a type of cancer of the gastrointestinal tract that is the leading cause of mortality worldwide. Purpose: Astilbin, a natural dihydroflavonol substance derived from a range of foods and medicinal herbs, has been shown in the current study to have anticancer potential against gastric cancer in AGS cell lines. Materials and Methods: The half maximal inhibitory concentration value was determined after astilbin was given to AGS cell lines at various doses. To verify apoptosis, the astilbin-treated cell line was subsequently stained with the dual dye acridine orange/ethidium bromide. AGS cell lines, the enzyme-linked immunosorbent assay (ELISA) approach was also used to investigate the inflammatory cytokines. Using ELISA, apoptotic marker expression including Bcl-2-associated X-protein, caspase-9 proteins, and B-cell lymphoma 2 was assessed in gastric cancer cells treated with astilbin. Results: The study’s findings reveal that astilbin is a prime candidate for gastric cancer therapy since it causes apoptosis in AGS cells and has a stronger effect on the major inflammatory markers of the disease. Conclusion: The study provides comprehensive methodologies and tools for predicting absorption, distribution, metabolism, excretion, and toxicity properties, facilitating informed decision-making in the development and optimization of astilbin as a gastric cancer therapy.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Zhang, G., Zhuang, X., Lin, S., & Wang, Y. (2024). Astilbin Inhibits the Proliferation and Induces Apoptosis of Gastric Cancer Cells (AGS) by Targeting the Key Inflammatory Markers. Pharmacognosy Magazine, 20(4), 1276–1285. https://doi.org/10.1177/09731296241264612